In this study, we focused on CCR1, CCR5, CCR6, CCR10, CX3CR1, CXCR2, CXCR4, ACKR1, ACKR2 and ACKR3, whose expression is detected in patient glioma tissue and rather well correlated with disease severity. Here, CCR1 is linked to central nervous system cancer.